168 related articles for article (PubMed ID: 25196816)
1. Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5-fluorouracil.
Tajiri K; Kawai K; Minemura M; Yasumura S; Hosokawa A; Kawabe H; Tomizawa G; Sugiyama T
Hepatol Res; 2015 Jul; 45(7):755-63. PubMed ID: 25196816
[TBL] [Abstract][Full Text] [Related]
2. Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.
Terashima T; Yamashita T; Iida N; Yamashita T; Nakagawa H; Arai K; Kitamura K; Kagaya T; Sakai Y; Mizukoshi E; Honda M; Kaneko S
Hepatol Res; 2015 Sep; 45(9):949-959. PubMed ID: 25319848
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy.
Oh MJ; Lee HJ; Lee SH
Clin Mol Hepatol; 2013 Sep; 19(3):288-99. PubMed ID: 24133667
[TBL] [Abstract][Full Text] [Related]
4. Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma.
Kawaoka T; Aikata H; Hyogo H; Morio R; Morio K; Hatooka M; Fukuhara T; Kobayashi T; Naeshiro N; Miyaki D; Hiramatsu A; Imamura M; Kawakami Y; Takahashi S; Waki K; Tsuji K; Kohno H; Kohno H; Moriya T; Chayama K
J Dig Dis; 2015 Sep; 16(9):505-12. PubMed ID: 26121102
[TBL] [Abstract][Full Text] [Related]
5. Automatic prediction of hepatic arterial infusion chemotherapy response in advanced hepatocellular carcinoma with deep learning radiomic nomogram.
Xu Z; An C; Shi F; Ren H; Li Y; Chen S; Dou J; Wang Y; Yan S; Lu J; Chen H
Eur Radiol; 2023 Dec; 33(12):9038-9051. PubMed ID: 37498380
[TBL] [Abstract][Full Text] [Related]
6. Combination of neutrophil-to-lymphocyte ratio and early des-γ-carboxyprothrombin change ratio as a useful predictor of treatment response for hepatic arterial infusion chemotherapy against advanced hepatocellular carcinoma.
Tsunematsu S; Suda G; Yamasaki K; Kimura M; Takaaki I; Umemura M; Ito J; Sato F; Nakai M; Sho T; Morikawa K; Ogawa K; Kamiyama T; Taketomi A; Sakamoto N
Hepatol Res; 2017 May; 47(6):533-541. PubMed ID: 27423140
[TBL] [Abstract][Full Text] [Related]
7. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Choi JH; Chung WJ; Bae SH; Song DS; Song MJ; Kim YS; Yim HJ; Jung YK; Suh SJ; Park JY; Kim DY; Kim SU; Cho SB
Cancer Chemother Pharmacol; 2018 Sep; 82(3):469-478. PubMed ID: 29982870
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched Analysis.
Zaizen Y; Nakano M; Fukumori K; Yano Y; Takaki K; Niizeki T; Kuwaki K; Fukahori M; Sakaue T; Yoshimura S; Nakazaki M; Kuromatsu R; Okamura S; Iwamoto H; Shimose S; Shirono T; Noda Y; Kamachi N; Koga H; Torimura T
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771452
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma after sorafenib.
Terashima T; Yamashita T; Arai K; Sunagozaka H; Kitahara M; Nakagawa H; Kagaya T; Mizukoshi E; Honda M; Kaneko S
Hepatol Res; 2014 Nov; 44(12):1179-85. PubMed ID: 24171787
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of hepatic arterial infusion chemotherapy as an alternative to sorafenib in advanced hepatocellular carcinoma.
Jeong SW; Jang JY; Lee JE; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Kim KH; Kim YJ
Asia Pac J Clin Oncol; 2012 Jun; 8(2):164-71. PubMed ID: 22524575
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of bi-monthly hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma.
Moriya K; Namisaki T; Sato S; Douhara A; Furukawa M; Kawaratani H; Kaji K; Kitade M; Shimozato N; Sawada Y; Seki K; Saikawa S; Takaya H; Akahane T; Mitoro A; Okura Y; Yamao J; Yoshiji H
J Gastrointest Oncol; 2018 Aug; 9(4):741-749. PubMed ID: 30151271
[TBL] [Abstract][Full Text] [Related]
12. A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma.
Song MJ; Bae SH; Chun HJ; Choi JY; Yoon SK; Park JY; Han KH; Kim YS; Yim HJ; Um SH; Chung WJ; Hwang JS; Cho SB; Eun JR
Cancer Chemother Pharmacol; 2015 Apr; 75(4):739-46. PubMed ID: 25663125
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma.
Liu BJ; Gao S; Zhu X; Guo JH; Zhang X; Chen H; Wang XD; Yang RJ
World J Gastrointest Oncol; 2020 Jun; 12(6):663-676. PubMed ID: 32699581
[TBL] [Abstract][Full Text] [Related]
14. Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial.
Hatooka M; Kawaoka T; Aikata H; Inagaki Y; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Awai K; Masaki K; Waki K; Kohno H; Kohno H; Moriya T; Nagaoki Y; Tamura T; Amano H; Katamura Y; Chayama K
BMC Cancer; 2018 Jun; 18(1):633. PubMed ID: 29866075
[TBL] [Abstract][Full Text] [Related]
15. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M
Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752
[TBL] [Abstract][Full Text] [Related]
16. A new therapeutic assessment score for advanced hepatocellular carcinoma patients receiving hepatic arterial infusion chemotherapy.
Saeki I; Yamasaki T; Tanabe N; Iwamoto T; Matsumoto T; Urata Y; Hidaka I; Ishikawa T; Takami T; Yamamoto N; Uchida K; Terai S; Sakaida I
PLoS One; 2015; 10(5):e0126649. PubMed ID: 25992784
[TBL] [Abstract][Full Text] [Related]
17. Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma.
Park JY; Ahn SH; Yoon YJ; Kim JK; Lee HW; Lee DY; Chon CY; Moon YM; Han KH
Cancer; 2007 Jul; 110(1):129-37. PubMed ID: 17508408
[TBL] [Abstract][Full Text] [Related]
18. Comparison of hepatic arterial infusion chemotherapy and sorafenib in elderly patients with advanced hepatocellular carcinoma: A case series.
Nemoto T; Matsuda H; Nosaka T; Saito Y; Ozaki Y; Hayama R; Naito T; Takahashi K; Ofuji K; Ohtani M; Hiramatsu K; Suto H; Nakamoto Y
Mol Clin Oncol; 2014 Nov; 2(6):1028-1034. PubMed ID: 25279193
[TBL] [Abstract][Full Text] [Related]
19. Clinical effects and safety of intra-arterial infusion therapy of cisplatin suspension in lipiodol combined with 5-fluorouracil versus sorafenib, for advanced hepatocellular carcinoma with macroscopic vascular invasion without extra-hepatic spread: A prospective cohort study.
Nakano M; Niizeki T; Nagamatsu H; Tanaka M; Kuromatsu R; Satani M; Okamura S; Iwamoto H; Shimose S; Shirono T; Noda Y; Koga H; Torimura T;
Mol Clin Oncol; 2017 Dec; 7(6):1013-1020. PubMed ID: 29285366
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib versus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis.
Zhuang BW; Li W; Xie XH; Hu HT; Lu MD; Xie XY
Jpn J Clin Oncol; 2019 Sep; 49(9):845-855. PubMed ID: 31063184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
